For every life the coronavirus has claimed in the United States, many more people have been infected and have survived the illness, though some have not fully recovered.

Health care providers around the country are creating clinics dedicated to treating “long-haulers,” or those who suffer from COVID 19-related symptoms long after they have contracted the virus. Allegheny Health Network in April announced that it will open such a clinic in Pine, where patients can seek specialist care and participate in research that tracks individuals with long-term symptoms. In October, UPMC launched a similar clinic that provides patients with an initial assessment, followed by a recommendation for pertinent specialized care.

These clinics answer a real need for treatment, study and guidance as to whether and which patients require a medical determination of disability. It’s an issue that is beginning to crop up in the business sector.

Some research shows that about a third of people who experienced even mild cases of COVID-19 develop “long-term COVID,” also known as “long-haul COVID” and “long COVID.” For them, symptoms persist months after contracting the virus. Some patients across all age groups have reported more than 100 symptoms ranging from fatigue, headaches and “brain fog” to aches, heart palpitations and breathing difficulty. The symptoms have been reported as mild as well as debilitating.

Advertise with us

Doctors are finding their way in diagnosing and treating these long-term symptoms. The new specialized clinics will help establish best-practices protocols.

In the meantime, employers and disability insurers are struggling with how to handle long-haulers.

Some of those who are experiencing long-term COVID symptoms they say can’t work. Patients with long-term COVID represent the largest new influx of disability claimants, according to some reports. That leaves employers and insurers weighing how to respond to applications for disability.

An organization called the Long COVID Alliance has formed and has begun to lobby for those who are plagued with lingering impacts of a virus that has claimed the lives of millions. The alliance is a network of scientists, disease experts, drug developers and patient advocates. The National Institutes of Health has committed more than $1 billion in funding to long-term COVID research initiatives. This is where the clinics being established far and wide will come into play; they will provide the raw data and research needed to develop treatment strategies.

The availability of easily accessible specialized care for COVID long-haulers is a boon to the entire region, one that will contribute to the national effort to understand the lasting implications of this ongoing pandemic.